Circassia Group (CIR)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

24.45p
   
  • Change Today:
      0.45p
  • 52 Week High: 29.10
  • 52 Week Low: 12.93
  • Currency: UK Pounds
  • Shares Issued: 376.91m
  • Volume: 24,010
  • Market Cap: £92.16m
  • RiskGrade: 7

Adams increases stake in Circassia

By Josh White

Date: Friday 03 Jan 2020

LONDON (ShareCast) - (Sharecast News) - Adams announced on Friday that, on 2 January, it purchased an additional 2,400,000 ordinary shares in Circassia on the AIM market, at an average price of 19p per share, for a total cash consideration of £0.46m.
The AIM-traded firm said its total holding in Circassia now amounted to 3,075,000 ordinary shares, representing 0.82% of Circassia's currently issued share capital.

Following the investment, it said it had cash balances of around £1.0m.

"Circassia is a specialty commercial pharmaceutical company focused on respiratory disease which promotes innovative asthma management products, including the 'NIOX' asthma diagnosis and management products and the chronic obstructive pulmonary disease products 'Tudorza' and 'Duaklir', directly to specialist physicians in a number of key markets," the Adams board explained.

"Circassia is working to expand its portfolio further through in-licensing, partnering or acquisition."

It said Circassia's revenues totalled £27.9m for the six months ended 30 June, which - coupled with continued significant investment in development and marketing - resulted in an operating loss of £19.3m for that period.

Circassia held cash and cash equivalents of £21m as at 30 June.

On 5 December, Circassia reiterated the guidance it had given in its interim financial results, confirming that it anticipated full year 2019 revenues of between £60m and £65m, with a "dramatically reduced" net cash outflow in the second half of 2019 compared with the first half.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CIR Market Data

Currency UK Pounds
Share Price 24.45p
Change Today 0.45p
% Change 1.88 %
52 Week High 29.10
52 Week Low 12.93
Volume 24,010
Shares Issued 376.91m
Market Cap £92.16m
RiskGrade 7

CIR Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
5.69% above the market average5.69% above the market average5.69% above the market average5.69% above the market average5.69% above the market average
89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average89.29% above the sector average
Price Trend
26.23% above the market average26.23% above the market average26.23% above the market average26.23% above the market average26.23% above the market average
12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average12.28% above the sector average
Income Not Available
Growth
42.27% above the market average42.27% above the market average42.27% above the market average42.27% above the market average42.27% above the market average
54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average54.29% above the sector average

What The Brokers Say

Strong Buy 0
Buy 0
Neutral 0
Sell 0
Strong Sell 1
Total 1
strong_sell
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CIR Dividends

No dividends found

Trades for 03-Jul-2020

Time Volume / Share Price
12:09 1,000 @ 24.26p
12:06 424 @ 24.45p
12:02 40 @ 24.50p
11:54 5,091 @ 24.00p
11:52 7,000 @ 24.10p

CIR Key Personnel

Chair Francesco Granata
CFO Julien Cotta

Top of Page